Eisai, Mylan to promote anti-cancer drug brands in India

India |  News | 0 Comment | 23 Sep, 2019

Eisai Co., Ltd. has announced that Eisai’s subsidiary Eisai Pharmaceuticals India Pvt. Ltd. and Mylan N. V. subsidiary Mylan India have entered into a license agreement to promote and...Read more

Glenmark receives Orphan Drug Designation for GBR 1342

India |  News | 0 Comment | 17 Sep, 2019

Glenmark Pharmaceuticals has announced that the USFDA has granted Orphan Drug Designation to its bispecific antibody candidate GBR 1342 for the treatment of patients with multiple myeloma w...Read more

AI can help scale up healthcare delivery in India: Ashutosh Lawania

India |  Opinion | 0 Comment | 16 Sep, 2019

Can you throw some light on your recent expansion in Delhi-NCR? mfine is an AI powered, on-demand healthcare platform which enables on-demand outpatient health care services on our platfo...Read more

Israel's Zebra inks pact with India's Medsynaptic

India |  News | 0 Comment | 16 Sep, 2019

Zebra Medical Vision, the deep learning medical imaging analytics company, has announced its partnership with Medsynaptic Pvt Ltd, the leading PACS and Teleradiology company in India d...Read more

Biocon collaborates with China Medical System

India |  News | 0 Comment | 12 Sep, 2019

Biocon Ltd, Asia’s premier biopharmaceuticals company, has announced that it has signed a License and Supply Agreement with a subsidiary of China Medical System Holdings Ltd. (CMS) fo...Read more

3M supports Nobel Prize Series Event in India

India |  News | 0 Comment | 12 Sep, 2019

Nobel laureates and world-leading experts will meet in Delhi and Punjab India, to address the topic of “Teaching and Learning” at the Nobel Prize Series, Sept. 11-13, 2019. A n...Read more

Sanofi India to sell Ankleshwar site to Zentiva

India |  News | 0 Comment | 11 Sep, 2019

The Board of Directors of Sanofi India Limited (SIL) has approved a transaction for the slump sale and transfer of its manufacturing facility at Ankleshwar, Gujarat to Zentiva and...Read more

Lupin receives USFDA approval for Ethacrynic Acid Tablets USP

India |  News | 0 Comment | 10 Sep, 2019

Indian Pharma major Lupin Limited (Lupin) on 9 Sep 2019, announced that it has received approval for its Ethacrynic Acid Tablets USP, 25 mg, from the United States Food and Drug Administrat...Read more

Boehringer Ingelheim Expands KRAS Cancer Program with Lupin’s Clinical Stage MEK Inhibitor Compound

India |  News | 0 Comment | 09 Sep, 2019

Boehringer Ingelheim and Lupin Limited (Lupin) has announced a licensing, development and commercialization agreement for Lupin’s MEK inhibitor compound (LNP3794) as a potential targe...Read more

GVK BIO announces new appointment

India |  News | 0 Comment | 05 Sep, 2019

GVK BIO, a leading global Contract Research and Development Organisation (CRDO), has announced the promotion of Sudhir Kumar Singh, Ph.D., to the position of Chief Operating Officer and the...Read more

Biocon receives USFDA’s Complete Response Letter for insulin glargine

India |  News | 0 Comment | 03 Sep, 2019

Biocon said that the US Food and Drug Administration (US FDA) has issued a complete response letter (CRL) for the New Drug Application (NDA) for insulin glargine filed by partner Mylan.&nbs...Read more

Half of all safety warnings issued to drug manufacturers in India and China

India |  News | 0 Comment | 30 Aug, 2019

According to a report by  The Pharmaceutical Journal, The majority of warnings from European and US drug regulators are to drug manufacturing sites in India and China, r...Read more

Ajinomoto Bio-Pharma buys Indian API plant

India |  News | 0 Comment | 02 Sep, 2019

Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, has announced its intention to purchase the remain...Read more

Strides acquires USFDA approved manufacturing facility in the US

India |  News | 0 Comment | 28 Aug, 2019

Strides Pharma Science Limited (Strides) has announced that its step down subsidiary Strides Pharma Inc.(SPI) has acquired a USFDA(FDA) approved manufacturing facility in Florida, US from M...Read more

Lupin launches antidepressant drug

India |  News | 0 Comment | 23 Aug, 2019

Pharma major Lupin Limited (Lupin) announced the launch of Fluoxetine Tablets USP, 10 mg and 20 mg, having received an approval from the United States Food and Drug Administration (U.S. FDA...Read more

Lupin gets USFDA nod for Hydrocortisone Valerate cream

India |  News | 0 Comment | 22 Aug, 2019

Indian Pharma major Lupin Limited (Lupin) announced that it has received approval for its Hydrocortisone Valerate Cream USP, 0.2% from the United States Food and Drug Administration (U.S. F...Read more

Lupin to sell Japanese injectable biz to Neopharma group

India |  News | 0 Comment | 22 Aug, 2019

Indian Pharma major Lupin Limited (including its subsidiaries together referred to as   Lupin) announced that it has entered into a definitive agreement through its Japanese subsi...Read more

Dr. Reddy's Launches Vigabatrin in the US

India |  News | 0 Comment | 20 Aug, 2019

Dr. Reddy’s Laboratories Ltd. has announced the launch of Vigabatrin Powder for Oral Solution, USP in 500 mg per packet, a therapeutic equivalent generic version of Sabril® (vigab...Read more